FDA Adverse Event Injury Summary report: N

TELIGEN

MDR report key: 2040098 · Received April 5, 2011

Report

Report Number
2124215-2011-00362
Event Type
Injury
Date Received
April 5, 2011
Date of Event
October 28, 2010
Report Date
January 4, 2011
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

ALL AVAILABLE INFORMATION INDICATES THAT THE DEVICE REMAINS IN SERVICE. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

DEFIBRILLATION THRESHOLD TESTING WAS PERFORMED, RESULTING IN SHOCK IMPEDANCE MEASUREMENTS WITHIN NORMAL LIMITS. THE PATIENT'S PHYSICIAN WAS AWARE OF THE OUT OF RANGE IMPEDANCE MEASUREMENT AND HAD NOT ELECTED FOR FURTHER INTERVENTION AT THIS TIME.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT VARYING SHOCK IMPEDANCE MEASUREMENTS WERE DETECTED ON THIS DEVICE SYSTEM. THE MEASUREMENTS REMAINED WITHIN ACCEPTABLE LIMITS. APPROXIMATELY TWO MONTHS LATER, A SHOCK IMPEDANCE MEASUREMENT GREATER THAN 125 OHMS WAS OBSERVED. TO DATE, NO ADVERSE PATIENT EFFECTS WERE REPORTED FOR THIS CLINICAL OBSERVATION.

Description of Event or Problem · 1

--

Description of Event or Problem · 1

--

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED THAT THE PATIENT IMPLANTED WITH THIS DEVICE SYSTEM WAS TO BE BROUGHT INTO THE CLINIC FOR DEFIBRILLATION THRESHOLD TESTING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E102

Patients

Seq Age Sex Outcome Treatment
1 79 YR Life Threatening| R 0147| T135| E102